Trump's investments in Big Pharma

US President Donald Trump has entered into pricing agreements with 17 major pharmaceutical companies. He purchased equities in nine of these companies between Jan. 1, 2026, and March 31, 2026. The exact sums Trump invested are not disclosed; instead, the investments are reported as a range. The chart shows the minimum amount he invested in each company during that period, as well as the maximum investment he may have made.

The exact amounts that Donald Trump has invested in each company are not specified in the document from the US Office of Government Ethics. Instead, the investments are listed within a range. The range is shown in the graph.
Chart: Anja HaugeSource: U.S. Office of Government EthicsGet the dataCreated with Datawrapper